{"product_id":"global-next-generation-sequencing-market-growth-status-and-outlook-2023-2029","title":"Global Next Generation Sequencing Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Next Generation Sequencing Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing sales for 2023 through 2029. With Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing.\u003c\/p\u003e\n\n\u003cp\u003eThe global Next Generation Sequencing market size is projected to grow from US$ 3609.9 million in 2022 to US$ 4601.3 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eThe classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.\u003c\/p\u003e\n\n\u003cp\u003eNext-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic \u0026amp; Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.\u003c\/p\u003e \n\n\u003cp\u003eNorth America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.\u003c\/p\u003e  \n\n\u003cp\u003eEurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nTargeted Sequencing \u0026amp; Resequencing\u003cbr\u003e\nWhole Genome Sequencing\u003cbr\u003e\nWhole Exome Sequencing\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nWhole-genome Sequencing\u003cbr\u003e\nExome Sequencing\u003cbr\u003e\nTargeted Resequencing\u003cbr\u003e\nDe Novo Sequencing\u003cbr\u003e\nRNA Sequencing\u003cbr\u003e\nChIP Sequencing\u003cbr\u003e\nMethyl Sequencing\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\nAPAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\nEurope\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n454 Life Sciences Corporation (A Roche Company)\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nBiomatters, Ltd\u003cbr\u003e\nCLC Bio\u003cbr\u003e\nGATC biotech AG\u003cbr\u003e\nMacrogen\u003cbr\u003e\nBGI (Beijing Genomics Institute)\u003cbr\u003e\nIllumina\u003cbr\u003e\nLife Technology Corporation\u003cbr\u003e\nEMC Corporation\u003cbr\u003e\nDnastar\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 100 Pages \/ MCW16228532","offer_id":47646865752370,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-next-generation-sequencing-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}